Who We Are

ANANDA Scientific is a research driven biopharmaceutical company focused on developing life changing medicines for therapeutic indications such as PTSD, Social Anxiety Disorder, Opioid Use Disorder, and Radiculopathic Pain.

ANANDA’s patented delivery technology, improves the clinical effectiveness of cannabinoids and plant-derived compounds by enhancing bioavailability and absorption consistency, and shelf-life stability. Our core objective is to develop a diversified portfolio of premier pharmaceutical products with unparalleled effectiveness and quality.

We have clinical trial collaborations in place with academic institutions including the NYU Grossman School of Medicine, the Icahn School of Medicine at Mt. Sinai, the Geffen School of Medicine, UCLA, and the University of Nebraska Medical Center. The goal is to conduct our clinical trials with the ‘best in class’ investigators who understand the disease indications and are able to collaborate on well designed clinical trials.

We have built a scalable drug development infrastructure that ensures quality control through a robust quality assurance program at every step of the development process. We also maintain redundancy of the development supply chain to mitigate risks and ensure flexibility in our operations. The goal is to deliver meaningful and lasting outcomes for our stakeholders.